You appear to be offline. Some data may be unavailable until your connection is restored.
BDX
StockBecton Dickinson & Company
Price data not available
Description
Becton, Dickinson & Company (BD) is a global medical‑technology firm that designs, manufactures and sells a wide range of medical supplies, devices, laboratory equipment and diagnostic systems for hospitals, clinics, research labs and the pharmaceutical industry. Its product portfolio includes needles and syringes, IV catheters, specimen‑collection tubes, infusion pumps, automated dispensing cabinets, flow‑cytometry instruments and molecular‑diagnostic platforms. BD operates in the broader health‑care equipment and diagnostics sector and is organized into three segments—Medical, Life Sciences and Interventional. The company holds leading market positions in several core categories such as hypodermic needles, prefilled drug‑delivery systems and clinical‑diagnostic technologies, supported by a global footprint and a history of strategic acquisitions.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q1 FY27 | Feb 4, 2027 (est.) | — |
| Q4 FY26 | Nov 5, 2026 | $4.15 |
| Q3 FY26 | Aug 6, 2026 | $3.23 |
| Q2 FY26 | May 7, 2026 | $2.90 |
| Q1 FY26 | Feb 9, 2026 | $2.91 |
Stay ahead of BDX earnings
Get reminders ahead of BDX's next earnings report, so you always know when results are coming.